 Connection
Jessica Cardenas to Venous Thromboembolism
This is a "connection" page, showing publications Jessica Cardenas has written about Venous Thromboembolism.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
4.783 |
|
|
|
-
Sanders KE, Hatton GE, Mankame AR, Allen AC, Cunningham S, Van Gent JM, Fox EE, Zhang X, Wade CE, Cotton BA, Cardenas JC. Exposure to statin therapy decreases the incidence of venous thromboembolism after trauma. J Trauma Acute Care Surg. 2024 11 01; 97(5):690-696.
Score: 0.607
-
Mankame AR, Sanders KE, Cardenas JC. TIME-DEPENDENT CHANGES IN PROINFLAMMATORY MEDIATORS ARE ASSOCIATED WITH TRAUMA-RELATED VENOUS THROMBOEMBOLISM. Shock. 2023 11 01; 60(5):637-645.
Score: 0.583
-
Sanders KE, Holevinski S, Zhang X, Cotton BA, Cardenas JC. Soluble endothelial protein C receptor is an independent predictor of venous thromboembolism after severe injury: Secondary analysis of a prospective cohort study. Surgery. 2023 08; 174(2):376-381.
Score: 0.574
-
Cotton BA, Cardenas JC. Targeting Chemoprophylaxis in Venous Thromboembolism Using Biomarker Guidance-Reply. JAMA Surg. 2023 02 01; 158(2):221-222.
Score: 0.561
-
Chen-Goodspeed A, Dronavalli G, Zhang X, Podbielski JM, Patel B, Modis K, Cotton BA, Wade CE, Cardenas JC. Antithrombin Activity Is Associated with Persistent Thromboinflammation and Mortality in Patients with Severe COVID-19 Illness. Acta Haematol. 2023; 146(2):117-124.
Score: 0.556
-
Vincent LE, Talanker MM, Butler DD, Zhang X, Podbielski JM, Wang YW, Chen-Goodspeed A, Hernandez Gonzalez SL, Fox EE, Cotton BA, Wade CE, Cardenas JC. Association of Changes in Antithrombin Activity Over Time With Responsiveness to Enoxaparin Prophylaxis and Risk of Trauma-Related Venous Thromboembolism. JAMA Surg. 2022 08 01; 157(8):713-721.
Score: 0.542
-
Rahbar E, Cotton BA, Wade CE, Cardenas JC. Acquired antithrombin deficiency is a risk factor for venous thromboembolism after major trauma. Thromb Res. 2021 08; 204:9-12.
Score: 0.499
-
Cardenas JC, Wang YW, Karri JV, Vincent S, Cap AP, Cotton BA, Wade CE. Supplementation with antithrombin III ex vivo optimizes enoxaparin responses in critically injured patients. Thromb Res. 2020 03; 187:131-138.
Score: 0.454
-
Schriner JB, Triolo F, Gill BS, Cardenas JC, Olson SD, Cox CS. Low molecular weight heparin decreases pro-coagulant activity in clinical MSC products. Cytotherapy. 2024 02; 26(2):194-200.
Score: 0.149
-
Watson C, Saaid H, Vedula V, Cardenas JC, Henke PK, Nicoud F, Xu XY, Hunt BJ, Manning KB. Venous Thromboembolism: Review of Clinical Challenges, Biology, Assessment, Treatment, and Modeling. Ann Biomed Eng. 2024 Mar; 52(3):467-486.
Score: 0.148
-
Myers SP, Brown JB, Leeper CM, Kutcher ME, Chen X, Wade CE, Holcomb JB, Schreiber MA, Cardenas JC, Rosengart MR, Neal MD. Early versus late venous thromboembolism: A secondary analysis of data from the PROPPR trial. Surgery. 2019 09; 166(3):416-422.
Score: 0.109
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|